Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    OK!

    He left with no regrets

    March 24th, 2022‘He left with no regrets.’ Tri-Cities grad with cancer found connection on TikTok, Instagram BY ERIC ROSANE UPDATED MARCH 23, 2022 11:16 AM Friends and family look back on the life of Parker Morgan, a 21-year-old Kennewick native who died this...

    Read Article

    Conference on Rare Cancers: Great Unmet Medical Needs

    March 23rd, 2022Reaching out to all rare cancer groups/advocates/patients. April 26, 2022. Virtual & in-person event from Columbia U Herbert Irving Cancer Center, NYC - "Rare Cancers: Great Unmet Medical Needs". It's a CME conference for patients/advocates/PAGs...

    Read Article

    185 million investment to fast-track treatments for rare and ‘untreatable’ cancers

    March 23rd, 2022The Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) will establish Australia as a medical manufacturing hub: building links from research through to the clinic; creating jobs; changing lives. Professor David Thomas Media...

    Read Article

    Registrations are still open for the Virtual Dialogue:: Saturday, April 30 1:00PM – 2:30PM (EST / New York Time)

    March 19th, 2022Join Us: Registration is Still Open The Chondrosarcoma Foundation, Inc. will host their fourth International Forum / Virtual Dialogue featuring the following prominent experts to address new innovations, findings and technologies to improve the...

    Read Article

    Clinical Pathology Unknowns

    March 18th, 2022 The Johns Hopkins Department of Pathology is proud to announce the launch of a new web site, "Clinical Pathology Unknowns" (https://apps.pathology.jhu.edu/cp/), an interactive clinical pathology educational resource. This...

    Read Article

    Register for our Virtual Dialogue scheduled for April 30 at 1:00pm via Zoom

    March 6th, 2022The Chondrosarcoma Foundation, Inc. will host their fourth International Forum / Virtual Dialogue: Moving Forward in Diagnosing and Treating Chondrosarcoma. In the spirit of sharing and passing knowledge about Chondrosarcoma, we invite you to...

    Read Article

    Chondrosarcoma Foundation will host the Fourth Virtual Dialogue on Saturday, April 30 at 1:00PM EST / New York time VIA Zoom

    February 23rd, 2022The Chondrosarcoma Foundation, Inc. will host their fourth International Forum / Virtual Dialogue featuring the following prominent experts to address new innovations, findings and technologies to improve the treatment of Chondrosarcoma. Anthony P....

    Read Article

    Phase 2 Study of Dasatinib (Sprycel) in Patients With Alveolar Soft,Part Sarcoma, Chondrosarcoma, Chordoma, Epithelioid,Sarcoma, or Solitary Fibrous Tumor

    February 20th, 2022About 20% of people with chondrosarcoma responded to the drug (tumor shrinkage by 20%). On average people with CS were on the drug for about 4-5 months before it was deemed ineffective though. In looking at the criteria for CS patients on the...

    Read Article
    Skip to content